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Abstract
Aims: The aim of this split-mouth study was to investigate levels of tumour necrosis
factor alpha (TNF-a), transforming growth factor beta (TGF-b2) and interleukin-1 beta
(IL-1b) in gingival crevicular fluid (GCF) and peri-implant crevicular fluid (PICF)
after a 21-day-period of de novo plaque accumulation in the same patient.
Material and Methods: In 25 patients, samples of GCF and PICF were collected in
the sulcus of the tooth and of the implant after professional hygiene. After the no-
hygiene phase (21 days), second samples of GCF and PICF were taken. Third samples
were collected after 69 days of re-establishment oral hygiene techniques. The
crevicular fluids were used to determine the volume and the levels of TNF-a, TGF-b2
and IL-1b.
Results: The volume of the crevicular fluids increased significantly after 21 days of
plaque accumulation around teeth and implants and decreased significantly by 69 days.
TNF-a and TGF-b2 did not change significantly among the three different samples. A
significant increase of IL-1b was observed after plaque accumulation around the teeth
GCF, whereas in the PICF the increase was not statistically significant.
Conclusions: These data suggest that increased volumes of GCF and PICF could be
useful markers of early inflammation in gingival and peri-implant tissues. In the
presence of de novo plaque, implants showed lower, and nearly significant, levels of
IL-1b compared with teeth.
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Clinical trials and animal experiments
have demonstrated that plaque accumu-
lation around dental implants can result
in the development of an inflammatory
reaction in the peri-implant mucosa
(Pontoriero et al. 1994, Moon et al.
1999, Zitzmann et al. 2001, Gualini &
Berglundh 2003, Quirynen et al. 2007).
The initiation and early development
of the lesion can be induced by bac-
terial metabolites, such as proteolytic
enzymes, by cell surface molecules,
like lipopolysaccharides (LPS), or by
host cells that release several types of
cytokines that can activate degradative
pathways (Birkedal-Hansen et al. 1988,
Birkedal-Hansen 1993, Okada &
Murakami 1998, Delaleu & Bickel 2004,
Orozco et al. 2006). Some researches
indicate that the tissue damage is caused
more by the host response, rather than
from direct bacterial action (Golub et al.
1997, Graves & Cochran 2003, Rathe
et al. 2007).
Recent studies show that in perio-
dontal and peri-implant tissues, cytokines
such as interleukin-1 beta (IL-1b),
tumour necrosis factor alpha (TNF-a)
and transforming growth factor beta
(TGF-b) have an important role in reg-
ulating and in amplifying the inflamma-
tory response (Panagakos et al. 1996,
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Delima et al. 2001, Graves & Cochran
2003).
One of the most important cytokines
in the inflammatory process in the oral
cavity is IL-1b, a multifunctional med-
iator that plays a major role in acute
and chronic periodontal inflammation. It
is a strong pro-inflammatory protein
because it mediates the production of
prostaglandins, leukotrienes and plate-
let-activating factor in several cell types.
Moreover, it promotes osteoclast forma-
tion and bone resorption (Gowen &
Mundy 1986, Billingham 1987, Tatakis
et al. 1988). High levels of IL-1b in
gingival crevicular fluid (GCF) (Hönig
et al. 1989, Masada et al. 1990, Engeb-
retson et al. 2002) and in gingival tissue
(Hönig et al. 1989, Stashenko et al.
1991, Engebretson et al. 1999) have
been associated with chronic perio-
dontitis (Masada et al. 1990, Ishihara
et al. 1997, Goutoudi et al. 2004, Orozco
et al. 2006). It has been shown that
inhibition of IL-1b reduced tissue
destruction and the progression of
inflammation in experimental perio-
dontitis (Graves et al. 1998, Delima
et al. 2001, Ataoglu et al. 2002, Delaleu
& Bickel 2004).
In peri-implant crevicular fluid
(PICF), higher levels of IL-1b have
been associated with peri-implantitis
(Kao et al. 1995, Panagakos et al.
1996, Salcetti et al. 1997, Aboyoussef
et al. 1998, Ataoglu et al. 2002, Murata
et al. 2002, Tsalikis et al. 2002).
TNF-a is another pro-inflammatory
cytokine with many functions similar
to those of IL-1b (Beutler & Cerami
1986, Sunderkotter et al. 1994). TNF-a
stimulates bone resorption and fibro-
blasts to produce collagenase (Bertolini
et al. 1986, Meikle et al. 1989). It
enhances apoptosis of matrix-producing
cells, limiting the repair capacity of the
periodontium (Graves et al. 2001, Hock
et al. 2001).
The involvement of TNF-a in peri-
implant mucositis or peri-implantitis is
not yet clear. It still has to be determined
whether this cytokine is a marker of
peri-implant health (Panagakos et al.
1996, Ataoglu et al. 2002).
TGF-b is a protein with anti-inflam-
matory properties and seems to have an
important role in regulating the devel-
opment and progression of periodontal
diseases (Sporn & Roberts 1990, Skale-
ric et al. 1997, Steinsvoll et al. 1999,
Buduneli et al. 2001, Wright et al. 2001,
2003). In the repair and regeneration
process of the periodontium, this cyto-
kine is a key feedback inhibitor of
bone resorption and stimulates bone
formation (Sporn & Roberts 1990,
Graves & Cochran 1994). The presence
of TGF-b has been shown in peri-
implant healthy tissue (Schierano et al.
2000, 2003). Few data exist on the
involvement of this cytokine in peri-
implantitis (Salcetti et al. 1997, Corne-
lini et al. 2003, Schultze-Mosgau et al.
2006), and no data exist regarding peri-
implant mucositis.
No data are available in literature on
the behaviour of these cytokines in the
both periodontal and peri-implant soft
tissues in the same patient. The aim of
this split-mouth study was to investigate
quantitative changes in IL-1b, TNF-a
and TGF-b2 levels in gingival and PICF
after experimental plaque accumulation
around a healthy implant and a healthy
tooth in the same patient.
Material and Methods
Study population
This split-mouth study protocol was
approved by the Local Ethics Board. All
patients gave informed written consent.
Twenty-five Caucasian patients (18
females, seven males, mean age
53  14) were enrolled in the study.
All patients were motivated and showed
good oral hygiene techniques. They did
not have a history of periodontitis and
no bleeding levels before the start of the
study. The patients were all non-smo-
kers in good general health and none
had taken medications, such as antibio-
tics or anti-inflammatory drugs, which
could affect their periodontal and peri-
implant health, for at least 6 months
before the study. All patients had been
rehabilitated with the implant-fixed
prosthesis (Branemark System, Nobel
Biocare AB, Göteborg, Sweden) for at
least 24 months before the start of the
study (Table 1).
An implant and a natural tooth sites
were selected in each patient. Table 1
also shows the position of the tooth and
implant abutment (length abutment:
one 5 3 mm; seventeen 5 4 mm; six 5
5 mm and one 5 5.5 mm).
Clinical recordings and CF collection
The oral hygiene of each patient was
monitored until the beginning of the
trial. When the study began, the patients
underwent a professional oral hygiene
session. One week after the professional
oral hygiene session (baseline/day 0),
the patients were asked to refrain from
performing any oral hygiene procedure,
to abstain from any kind of drug that
could affect cytokine production and to
avoid chewing ‘‘hard’’ foods (such as
raw vegetables), gum that could stimu-
late self-cleaning of the teeth, for 3
weeks. After this time (day 21), the
patients re-started cleaning their teeth
again. Three different samples of GCF
and PICF were taken at the following
times: the first at baseline/day 0; the
second at 21 days; and the third 3
months after baseline (day 90), i.e. 69
days after re-starting normal oral
hygiene.
At baseline, days 21 and 90, the
plaque index (PI; Silness & Löe 1965)
and gingival index (GI; Löe 1967) were
assessed (Table 2).
Two Periopaper absorbing strips
(Oraflow, Plainview, NY, USA) were
inserted into both the gingival and two
in the peri-implant crevice for 30 s,
one mesial-buccally and the other
disto-buccally.
The volume of the crevicular fluids
was determined by positioning the strips
between the upper and the lower coun-
terparts of the pre-calibrated Periotron
8000 (Oraflow); the volume of the cre-
vicular fluids was measured in ‘‘Perio-
tron units’’ and then converted into
microlitres.
The paper strips were then placed in a
single labelled test tube containing
350ml of phosphate–buffered saline
(PBS), sealed and immediately sent to
the lab. After 15 min. of shaking at room
temperature, the strips were removed
and the eluates were centrifugated
(5 min, 3000  g) to remove plaque
and cellular elements. The samples
were stored at  801C for subsequent
assays. The reported volumes and the
cytokine amounts were the average of
the two samples (mesial- and disto-
buccal) collected at each site.
Cytokine assays
The levels of TNF-a, TGF-b2 and IL-1b
were determined using commercial ELI-
SA kits (TNF-a, IL-1b: Euroclone Life
Sciences, Pero (MI), Italy; TGF-b2:
Promega Corporation, Madison WI,
USA). Hundred microlitres from each
eluted sample was assayed according to
the manufacturer’s instructions. The test
sensitivity is so high that it manages to
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detect TNF-a, TGF-b2 and IL-1b even
when the quantity is o8, 32, 5 pg/ml,
respectively, as indicated in the techni-
cal cards.
Before the assay, the samples used for
TGF-b2 determination were processed
by an in vitro acid treatment to obtain
the bioactive form of the protein (total
TGF-b2). Briefly, the specimens were
diluted 1:4 in Dulbecco’s PBS and acid-
ified with 1 N HCl (1 ml per 50 ml of
diluted sample), incubated at room tem-
perature for 15 min. and then neutralized
by adding 1 N NaOH (1 ml per 50ml of
diluted sample).
The amounts for each cytokine were
examined using a microplate reader at
450 nm as the primary wavelength and
at 620 nm as the reference wavelength.
Concentrations of the cytokines in
each 100 ml sample were determined
by generation of standard curves. Cyto-
kines are expressed as total amounts in
pg/site.
Statistical analysis
The reported volumes and cytokine total
amounts were the average of the two
samples collected at each site. Data are
expressed as means and standard de-
viations. Owing to the non-normal dis-
tribution of data, the non-parametric
Friedman’s test was used when compar-
ing the repeated measurements during
the follow-up. When the Friedman test
was significant at the 0.05 level, pair-
wise comparisons based on the Wilcox-
on rank test were carried out, with the
Bonferroni correction to adjust for mul-
tiple pairwise comparisons (a5 0.05/
3 5 0.016). Differences between tooth
and implant at each time point were
evaluated using the Wilcoxon rank test
with Bonferroni’s correction (a5 0.05/
3 5 0.016) to avoid an inflation of type I
error due to multiple analyses.
All statistical analyses were per-
formed using STATA 8.0 software.
Results
The clinical indices assessed demon-
strated that at the test sites, plaque
accumulation with gingival and peri-
implant mucosa inflammation was induced
after 21 days of no oral hygiene. Both
the PI and the GI increased in all
patients between days 0 and 21 and
returned to baseline values by day 90
(Table 2).
In all 25 patients, a significant
increase in GCF and PICF volume was
induced by non-brushing compared with
day 0. Samples collected at day 90
demonstrated a significant decrease in
GCF and PICF volume compared with
day 21 (Fig. 1). Although a significant
reduction in volume occurred after the
re-establishment of daily oral hygiene,
at day 90, the volume of the GCF from
the study teeth was still significantly
elevated compared with the baseline.
Instead, the PICF volume, at day 90,
returned to baseline levels. In compar-
ing the CGF and PICF volumes at the
times of evaluation, no significant dif-
ferences were noticed.
TNF-a was detected in all 25 patients;
no significant changes were detected
in the total level of this cytokine for
both the teeth and the implants during the
three experimental timings (p40.05).
The comparison of the total amount of
TNF-a detected in GCF with that in
PICF at all three sampling points
Table 2. Means and SDs of plaque index (PI; Silness & Löe 1965) and gingival index (GI; Löe
1967) of whole mouth. 0, no plaque; 1, visible plaque; 2, great accumulation of plaque
11 sample 21 sample 31 sample
Plaque index (PI)
25 patients 0.00  0.00 1.00  0.00 0.00  0.00
Gingival index (GI)
25 patients 0.00  0.00 1.16  0.37 0.24  0.43
Table 1. Subject characteristics of study population
Patient Age Sex Social background Total natural teeth Total implants Site tooth selected Site implant selected
1 68 F Psychologist 22 4 33 34
2 70 F Housewife 18 6 26 25
3 47 F Laboratory technician 24 1 22 23
4 60 M Administration employee 23 3 33 36
5 71 F Retired 21 4 35 36
6 69 M Retired 20 4 22 23
7 49 F Administration employee 23 4 27 26
8 47 F Nurse 16 5 35 34
9 60 M Driver 27 1 47 46
10 65 F Teacher 17 7 43 45
11 64 F Administration employee 16 5 27 24
12 24 F Administration employee 30 1 34 35
13 53 F Administration employee 22 5 25 24
14 67 F Administration employee 14 9 34 35
15 28 M Student 30 2 14 12
16 52 F Cashier 20 3 34 35
17 34 M Administration employee 26 3 15 13
18 63 F Retired 21 2 26 25
19 46 M Worker 27 1 16 14
20 41 F Administration employee 23 2 33 24
21 34 F Administration employee 25 2 33 34
22 36 F Teacher 29 1 44 43
23 60 M Retired 16 3 26 22
24 63 F Retired 13 5 17 16
25 50 F Worker 23 2 22 12
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showed no significant difference
(p40.05, Fig. 2).
TGF-b2 was observed in all crevicu-
lar fluid samples, around implants and
teeth, but no significant change in the
total amount of this cytokine was
detected in the study (p40.05). More-
over, no significant differences were
observed on comparing the GCF values
with PICF at the three sampling points
(p40.05, Fig. 3).
IL-1b was also detected in all 25
patients. In the GCF, a significant
increase in the total amount of this
cytokine was detected at day 21 com-
pared with the baseline. The re-estab-
lishment of oral hygiene induced a
significant reduction by day 90. No
significant difference was observed
between the total amount of cytokine
at day 90 and baseline (Fig. 4).
Twenty-one days of plaque accumu-
lation in the PICF induced a non sig-
nificant increase of IL-1b levels, while
at day 90, a significant reduction of this
cytokine was detected, the amount being
similar to that at baseline (Fig. 4).
At day 21, the total amount of IL-1b
in the GCF was higher than in the PICF,
but this difference was not significant at
the 0.016 level fixed with the Bonferroni
correction for multiple analyses
(p 5 0.0382). No significant differences
were found at day 0 or 90.
Discussion
This split-mouth study evaluated the
trends of volume and cytokines in
GCF and PICF before and after plaque
accumulation in the same patient. For
this reason, the data are not affected by
individual changes. Other studies have
not analysed these parameters in the
same patient (Lamster et al. 1985, Niimi
& Ueda 1995, Panagakos et al. 1996,
Salcetti et al. 1997, Ataoglu et al. 2002,
Murata et al. 2002, Eberhard et al. 2003,
Wright et al. 2003).
The results of the present study con-
firm previous findings (Löe et al. 1965,
Zitzmann et al. 2001, Wright et al.
2003) and clearly demonstrate that
when oral hygiene procedures are inter-
rupted, an increase in plaque accumula-
tion and the establishment of clinically
relevant mucosal inflammation occur
around both dental implants and teeth.
A relationship between GCF and gin-
gival inflammation has been reported
previously (Lamster et al. 1985,
Eberhard et al. 2003). In this study, all
patients showed a significant increase in
GCF volume after 21 days of no oral
hygiene. After oral care was resumed,
this volume decreased significantly
(Wright et al. 2003).
The PICF volume increased signifi-
cantly after plaque accumulation (day
21) compared with day 0, as observed in
other studies (Niimi & Ueda 1995,
Salcetti et al. 1997, Murata et al.
2002). After resuming oral hygiene
techniques, the PICF volume decreased
significantly. This is the first study
demonstrating that oral hygiene can
reduce peri-implant mucosal inflamma-
tion, as assessed by PICF volume, in a
69-day period (90–21 days). These data
suggest that increased volumes of GCF
and PICF could be useful markers of
early (21 days) inflammation in gingival
and peri-implant tissues.
In contrast with other studies (Wright
et al. 2003), the GCF decreased around
the study teeth 69 days after the re-
establishment of hygiene procedures,
but was still significantly higher than
at baseline, even if, clinically, the gin-
gival tissues appeared healthy. The fact
that GCF did not return to baseline as it
occurred for PICF could be explained by
the anti-inflammatory effect of titanium,
Fig. 1. Boxplots of crevicular fluid volume around teeth and implants. Outliers were not
plotted, but included in the statistical analysis. Sample 1, day 0; sample 2, day 21; sample 3,
day 90. nStatistical significance.
Fig. 2. Boxplots of mean values of TNF-a (total amount, pgtot) around teeth and implants.
TNF-a, tumour necrosis factor alpha. Outliers were not plotted, but included in the statistical
analysis. Sample 1, day 0; sample 2, day 21; sample 3, day 90.
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as shown in in vitro studies (Larsson
et al. 2004, Contreras et al. 2007).
With respect to cytokines, most of the
patients had measurable TNF-a levels,
but no significant change in the overall
amount was evident after the establish-
ment of plaque-associated mucosal
inflammation. This result is similar to
the one of Ataoglu et al. (2002), who
detected TNF-a in 37 of 42 implant
samples, but found no correlation
between the severity of peri-implant
inflammation and the presence of TNF-
a. It remains unclear whether the level
of this cytokine in PICF and CGF can be
considered to be a measure of tissue
health.
TGF-b2 has been detected at all
experimental timings. Despite the
reported involvement of this cytokine
in the repair process of insults in the
periodontium (Sporn & Roberts 1990,
Graves & Cochran 1994), no significant
change in the total amount was detected
after 21 days of plaque accumulation or
69 days after the re-establishment of
oral hygiene, nor was any difference
detected when implants were compared
with teeth. These data confirm the
results of a study in which no significant
increase was found in TGF-b1 after 14
and 21 days of plaque accumulation
following the induction of experimental
gingivitis (Wright et al. 2003). These
results may suggest that 21 days of
plaque accumulation around implants
and teeth are not sufficiently severe to
stimulate changes in the level of this
cytokine. Perhaps an established and
chronic lesion may be necessary to
stimulate a significant production of
TGF-b isoforms.
IL-1b was the only cytokine exam-
ined that demonstrated significant
changes during the study. A signifi-
cantly increased level of this cytokine
was detected after plaque accumulation
in the crevicular fluid of teeth. These
results confirm the findings of other
studies showing increased IL-1b crevi-
cular fluid levels after induction of
experimental gingivitis with de novo
plaque accumulation (Gonzales et al.
2001, Tsalikis et al. 2002, Giannopoulou
et al. 2003).
The resumption of oral hygiene tech-
niques produced a significant reduction
in IL-1b, as detected at day 90, and a
recovery in gingival health as observed
clinically. This further demonstrated
how this cytokine is correlated with
the early phases of the gingival inflam-
matory process, in addition to chronic
gingivitis and periodontitis (Faizuddin
et al. 2003, Goutoudi et al. 2004, Orozco
et al. 2006).
The PICF analyses showed that at day
21, an increase in the total amount of IL-
1b occurred, but it was not statistically
significant compared with the baseline
values. After 69 days of resumed oral
hygiene, a significant reduction in the
cytokine level was detected. At day 90,
the amount of IL-1b present in the PICF
was similar to the baseline. In perio-
dontal disease, several studies have
demonstrated a correlation between
this cytokine and established peri-
implantitis (Kao et al. 1995, Panagakos
et al. 1996, Aboyoussef et al. 1998,
Murata et al. 2002); the present study
is the first to assess changes in IL-1b
before, during and after the resolution of
a peri-implant mucositis.
Comparing the content of IL-1b in
CGF and PICF, it is possible to observe
a higher, but not significant, amount of
this cytokine at day 21 in the CGF. The
biological mechanism involved is still
unclear; a possible explanation may be the
previously mentioned anti-inflammatory
Fig. 3. Boxplots of mean values of TGF-b2 (total amount, expressed in pgtot) around teeth
and implants. TGF-b, transforming growth factor beta. Outliers were not plotted, but included
in the statistical analysis. Sample 1, day 0; sample 2, day 21; sample 3, day 90.
Fig. 4. Boxplots of mean values of IL-1b (total amount, expressed in pg tot) around teeth and
implants. IL-1b, interleukin-1 beta. Outliers were not plotted, but included in the statistical
analysis. Sample 1, day 0; sample 2, day 21; sample 3, day 90. nStatistical significance.
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property of titanium surfaces (Larsson
et al. 2004, Contreras et al. 2007).
After analysing the data, we reached
the following conclusions.
1) Re-establishment of oral hygiene can
restore the health of mucosal tissues,
even after 3 weeks of plaque accu-
mulation around teeth and implants.
(2) GCF and PICF volume are corre-
lated with gingival and peri-implant
mucosal inflammation; the crevicu-
lar fluid volume around teeth and
implants may be an index for the
evaluation of the presence of soft
tissue inflammation.
(3) The amount of IL-1b in the CGF
and PICF may be parameters that
could be considered to evaluate the
inflammatory process.
(4) In the presence of de novo plaque,
implants showed lower, and nearly
significant, levels of IL-1b com-
pared with teeth.
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Löe, H., Theilade, E. & Jensen, S. B. (1965)
Experimental gingivitis in man. Journal of
Periodontology 36, 177–178.
Masada, M. P., Persson, R. & Kenney, J. S.
(1990) Measurement of interleukin 1a and 1b
in gingival crevicular fluid: implication for
the pathogenesis of periodontal disease.
Archives Oral Biology 25, 156–163.
Meikle, M. C., Atkinson, S. J., Ward, R. V.,
Murphy, J. & Reynolds, J. J. (1989) Gingival
fibroblasts degrade type 1 collagen films
when stimulated with tumor necrosis factor
and IL-1 evidence that breakdown is
mediated by metalloproteinase. Journal of
Periodontal Research 24, 207–213.
Moon, I.-S., Berglundh, T., Abrahamsson, I.,
Linder, E. & Lindhe, J. (1999) The barrier
between the keratinized mucosa and the
dental implant. An experimental study in
the dog. Journal of Clinical Periodontology
26, 658–663.
Murata, M., Tatsumi, J., Kato, Y., Suda, S.,
Nunokawa, Y., Kobayashi, Y., Takeda, Y.,
Arakai, H., Shin, K., Okuda, K., Miyata, T. &
Yoshie, H. (2002) Osteocalcin, deoxypyridi-
noline and interleukin 1b in peri-implant
crevicular fluid of patients with peri-implan-
titis. Clinical Oral Implant Research 13,
637–643.
Niimi, A. & Ueda, M. (1995) Crevicular fluid in
the osseointegrated implant sulcus: a pilot
study. International Journal of Oral Maxillo-
facial Implants 10, 434–436.
Okada, H. & Murakami, S. (1998) Cytokine
expression in periodontal health and disease.
Critical Review in Oral Biology and Medi-
cine 9, 248–266.
Orozco, A., Gemmel, E., Bickel, M. & Sey-
mour, G. J. (2006) Interleukin 1b, interleu-
kin-12 and interleukin-18 levels in gingival
fluid and serum of patients with gingivitis and
periodontitis. Oral Microbiology Immunol-
ogy 21, 256–260.
Panagakos, F. S., Aboyoussef, H., Dondero, R.
& Jandinski, J. J. (1996) Detection and
measurement of inflammatory cytokines in
implant crevicular fluid: a pilot study. Inter-
national Journal of Oral Maxillofacial
Implants 11, 794–799.
Pontoriero, R., Tonelli, M. P., Carnevale, G.,
Mombelli, A., Nyman, S. R. & Lang N, P.
(1994) Experimentally induced peri-implant
mucositis. A clinical study in humans. Clin-
ical Oral Implant Research 5, 254–259.
Quirynen, M., Abarca, M., Van Assche, N.,
Nevins, N. & van Steenberghe, D. (2007)
Impact of supportive periodontal therapy and
implant surface roughness on implant out-
come in patients with a history of perio-
dontitis. Journal of Clinical Periodontology
34, 805–815.
Rathe, F., Auschill, T. M., Sculean, A., Gauds-
zuhn, Ch. & Arweiler, N. B. (2007) The
plaque and gingivitis reducing effect of a
chlorhexidine and aluminium lactate contain-
ing dentifrice (Lacalut aktivs) over a period
of 6 months. Journal of Clinical Perio-
dontology 34, 646–651.
Salcetti, J. M., Moriarty, J. D., Cooper, L. F.,
Smith, F. W., Collins, J. C., Socransky, S. S.
& Offembacher, S. (1997) The clinical,
microbiological and host response character-
istics of the failing implant. International
Journal of Oral Maxillofacial Implants 12,
32–42.
Schierano, G., Bassi, F., Gassino, G., Mareschi,
K., Bellone, G. & Preti, G. (2000) Cytokine
production and bone remodelling in patients
wearing overdentures on oral implants. Jour-
nal of Dental Research 79, 1675–1682.
Schierano, G., Bellone, G., Cassarino, E., Paga-
no, M., Preti, G. & Emanuelli, G. (2003)
Transforming growth factor-beta and inter-
leukin 10 in oral implant sites in humans.
Journal of Dental Research 82, 428–432.
Schultze-Mosgau, S., Wehrhan, F., Wichmann,
M., Schlegel, K. A., Holst, S. & Thorwarth,
M. (2006) Expression of interleukin 1-beta,
transforming growth factor beta-1, and vas-
cular endothelial growth factor in soft tissue
over implant before uncovering. Oral Sur-
gery Oral Medicine Oral Pathology Oral
Radiology and Endodontics 101, 565–571.
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Scientific rationale for the study:
some cytokines appear to have roles
in regulating inflammatory response
amplification because in periodontal
and peri-implant tissues, inducing
osteoclastic bone resorption and con-
nective tissue degradation, the levels
of cytokines were assessed in crevi-
cular fluid to evaluate the periodontal
and peri-implant inflammation.
Principal findings: GCF and PICF
volumes increased in the presence
of plaque accumulation and were
correlated with gingival and peri-
implant mucosal inflammation.
Practical implications: the crevicular
fluid volumes and IL-1b content
around teeth and implants may pro-
vide an index for the evaluation of the
presence of soft tissue inflammation.
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